Gastrointestinal system

Published on 27/05/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1048 times

CHAPTER 6 GASTROINTESTINAL SYSTEM

GASTROINTESTINAL TRACT IN CRITICAL ILLNESS

The gastrointestinal tract plays a major role in the pathophysiology of critical illness. In addition, to being a common site for surgical intervention and a common source of intra-abdominal sepsis, the gut is pivotal during critical illness in a number of ways:

Manifestations of gastrointestinal tract failure

Failure of the gastrointestinal tract during critical illness may present in a number of ways. These are listed in Box 6.1.

The principle aim of investigation of gastrointestinal dysfunction in the critically ill patients is to exclude serious, remediable, intra-abdominal pathology. In some cases, the combination of history, clinical examination and blood results in the context of the overall clinical picture will suffice. In many cases however, intra-abdominal imaging will be required. Occasionally laparotomy or laparoscopy may be necessary to exclude serious pathology.

REDUCED GASTROINTESTINAL MOTILITY

DIARRHOEA

Diarrhoea is a common manifestation of gastrointestinal tract failure in the intensive care unit and may arise in a number of ways

GASTROINTESTINAL BLEEDING

Slow bleeding from the gastrointestinal tract may occur, and is a common cause of reduced haemoglobin in the critically ill. Less commonly, but of greater immediate concern is acute massive GIT haemorrhage, which may be life threatening. The source is usually the upper GIT. Common causes are listed in Box 6.2. Bleeding of this sort can result in haematemesis, melaena or even frank rectal blood loss. Lower GIT bleeding is less common, but may still be life threatening.

HEPATIC DYSFUNCTION DURING CRITICAL ILLNESS

Liver dysfunction (as opposed to liver failure) is common during critical illness, particularly in association with severe shock states in which there is relative splanchnic and liver hypoperfusion. It is characterized by progressive rise in bilirubin, abnormalities of liver enzymes, coagulopathy with raised prothrombin time (PT) and delayed drug metabolism. Ultrasound or CT scan should be performed to exclude localized collections of infected fluid or biliary tract obstruction. The management is essentially supportive. Hepatotoxic drugs should be stopped. Liver function should improve as the patient’s general condition improves.

HEPATIC FAILURE

Liver failure is defined as hyperacute where the onset of encephalopathy occurs within 7 days of the onset of jaundice, acute where the interval is 7–28 days, and subacute where it is between 28 days and 6 months. Longer intervals represent chronic liver failure. The term fulminant liver failure refers to an earlier classification where encephalopathy occurs within 8 weeks of the onset of jaundice. It thus encompasses acute and hyperacute liver failure.

Pathophysiology

The final common pathway is hepatocellular failure, with a reduction or loss of the synthetic, homeostatic and filter functions of the liver. This results in a failure of carbohydrate metabolism, depletion of glycogen stores and consequent hypoglycaemia. Deranged amino acid metabolism results in accumulation of ammonia and other intermediate compounds, which account in part for the development of encephalopathy.

Protein synthesis is arrested, and this includes the synthesis of albumin and clotting factors. Coagulopathy is invariable. PT is the most sensitive index of hepatocellular failure and recovery. The coagulopathy may be exacerbated by activated fibrinolysis.

The filter (reticuloendothelial) functions of the hepatic Kupffer cells are central to the prevention of translocation of gut-derived endotoxin to the systemic circulation. In acute liver failure, there is systemic endotoxaemia. Further, the massive necrosis of hepatocytes releases high levels of tumour necrosis factor (TNF), platelet-activating factor (PAF) and other proinflammatory cytokines. Systemic inflammatory response syndrome (SIRS) and multisystem organ failure (MOF) follow. Moreover, there is a steep rise in circulating ammonia concentration. This is thought to mediate an increase in excitatory neurotransmitters in the central nervous system. The combination of these effects gives rise to failure of the blood–brain barrier, with cerebral oedema and altered consciousness (encephalopathy).

Clinical features

Hypoglycaemia is common and develops any time in the first few days of the condition. It gradually resolves as the liver failure improves. Acid – base homeostasis is altered and either alkalosis or acidosis may complicate this. A metabolic acidosis is the more sinister. Concurrently with the development of the metabolic derangement, conscious level may become impaired. Encephalopathy is graded as in Table 6.1.

TABLE 6.1 Grading of hepatic encephalopathy

Grade 0 Normal
Grade 1 Mild confusion (may not be immediately evident)
Grade 2 Drowsiness
Grade 3 Severe drowsiness, inappropriate words/phrases, grinding teeth
Grade 4 Unrousable

The onset of encephalopathy is followed in some patients by cerebral oedema and raised intracranial pressure (ICP). The risk of raised ICP is greatest in hyperacute liver failure (in excess of 50% of cases), and much lower in acute failure. It is much less common in subacute failure (around 4%). A baseline elevation in ICP up to 20–25 mmHg may be followed by surges, which are transient but severe (up to 80–90 mmHg). This stage may be followed by inexorably rising ICP and brain death.

The haemodynamics of SIRS develop as conscious level reaches grade III–IV. The characteristic hypotension is associated with a high cardiac index and low systemic vascular resistance. Vasodilatation and increased capillary permeability contribute to reduced circulating volume and may predispose to renal failure. Acute tubular necrosis may also occur as a result of SIRS or directly as a result of the precipitating insult, e.g. paracetamol-induced renal damage.

The coagulopathy seldom gives rise to de novo bleeding, even though very high PT values are seen (>100 s). Generalized oozing around cannulation sites is common but is seldom of great significance. Thrombocytopenia may also occur, either due to DIC or hypersplenism. It is occasionally necessary to perform invasive procedures under platelet cover.

True‘infective’ sepsis may occur. A rising WCC, falling platelet count, a PT whose recovery becomes arrested or a worsening acidosis should all be regarded as suspicious.

Management

ACUTE PANCREATITIS

Inflammation of the pancreas and autodigestion may be precipitated by a number of triggers, some of which are listed in Box 6.3. The commonest causes are alcohol and biliary obstruction. Frequently no cause can be identified.

Management

Severe cases should be referred to specialist centres. In milder cases supportive treatment and analgesia are the main requirements. Pethidine theoretically causes less spasm of the sphincter of Oddi than morphine. Hyperglycaemia is managed by sliding scale insulin infusion. Traditionally, the GI tract is rested by insertion of a nasogastric tube and regular drainage/aspiration. Total parenteral nutrition is frequently introduced early in the condition. These views are currently undergoing reappraisal; some studies suggest that very early enteral feeding reduces mortality.

In some centres, octreotide (25 μg hourly by infusion) or lanreotide are used to reduce exocrine activity. Patients who develop SIRS/ARDS require intubation, ventilation and haemodynamic optimization. These patients may benefit from antioxidant regimens. Acute renal failure may require renal replacement therapy. Particular attention should be paid to acid – base balance and electrolyte disorders. Repeated calcium, phosphate and magnesium supplementation are often required.

Pancreatic cyst/pseudocyst formation requires expert surgical intervention. Treatment may be conservative, by radiologically guided drainage, or by surgical excision. The latter may require repeated laparotomy for intra-abdominal sepsis.

The role of prophylactic antibiotics in severe pancreatitis has been widely debated and controversial in recent years. The best evidence currently available suggests that prophylactic use of antibiotics is associated with an increased mortality, and that antibiotic use should be guided according to culture results. Because pancreatitis is associated with a brisk SIRS response, it is tempting to introduce antibiotics in the absence of infection. This temptation should be resisted!